Regulation of the extrarenal CYP27B1-hydroxylase.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms and disease pathways without systematic search or original human data
PubMed 24388948 · doi:10.1016/j.jsbmb.2013.12.009
What was done
This narrative review summarizes research on the regulation and local immune functions of extrarenal CYP27B1-hydroxylase, focusing on intracrine and paracrine vitamin D metabolism in granuloma-forming conditions such as tuberculosis. The review details how microenvironmental cytokines influence local synthesis of active 1,25-dihydroxyvitamin D [1,25(OH)2D] by activated macrophages.
What was found
The abstract reports qualitative mechanistic pathways without numerical data. Macrophage CYP27B1 converts 25-hydroxyvitamin D [25(OH)D] to 1,25(OH)2D under the stimulation of Type II interferon (IFN-γ), a response linked to more confined disease phenotypes. Conversely, Type I interferons (IFN-α and IFN-β) inhibit this hydroxylation reaction and correlate with more aggressive disease. Fostering a confined disease phenotype requires sufficient extracellular 25(OH)D substrate to support IFN-γ-driven intracellular 1,25(OH)2D synthesis.
Why it matters
It outlines how local immune defenses depend on non-renal vitamin D activation by macrophages, providing a mechanistic rationale for how adequate circulating 25(OH)D supports localized immune containment in granulomatous infections.
Limits
The abstract describes a narrative conceptual overview without systematic review methodology, meta-analytic data, sample sizes, or quantitative statistical results. Clinical outcomes of substrate supplementation are not directly tested or quantified in the text provided.
Cited by
- supports Circulating 25-hydroxyvitamin D is converted into active 1,25-dihydroxyvitamin D not only in the kidneys but also locally within white blood cells.